Clinical Trials Sponsored by Momentum Pharma

Total 8315 results

Momentum Data

Completed

Comorbidities and Outcomes in Early Rheumatoid Arthritis

Rheumatoid Arthritis

United Kingdom
Escape Bio, Inc.
Momentum Pharma; Science 37

Terminated

A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene

United States
Momentum Data
Pfizer

Completed

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Vitiligo | Melanoma (Skin) | Actinic Keratoses | Basal Cell Carcinoma | Squamous Cell Carcinoma | Nonmelanoma Skin Cancer

United Kingdom
Momentum Data
Pfizer

Completed

Mental Health Associations With Vitiligo

Anxiety Disorders | Suicide, Attempted | Vitiligo | Self-Harm, Deliberate | Substance Abuse | Social Phobia | Overdose | Adjustment Disorders | Depressive Episode | Recurrent Depressive Disorder | Parasuicide

United Kingdom
Momentum Data
Pfizer

Active, not recruiting

Investigating Healthcare Disparities in Vitiligo

Vitiligo

United Kingdom
Momentum Data
Pfizer

Completed

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Allergic Rhinitis | Deep Vein Thrombosis | Venous Thromboembolism | Atopic Dermatitis | Pulmonary Embolism | Food Allergy | Allergy to House Dust Mite | Allergy to Animal Dander | Cows Milk Allergy

United Kingdom
Windtree Therapeutics
Momentum Research, Inc.

Active, not recruiting

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC)

Cardiogenic Shock

United States, Italy, Poland, Argentina
Nile Therapeutics
Momentum Research, Inc.

Completed

Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) (PreCONDITION)

Acute Decompensated Heart Failure

Russian Federation
Momentum Data
Optimum Patient Care

Completed

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

Schizophrenia | Inflammatory Bowel Diseases | Bipolar Disorder | Sleep Disturbance | Suicide, Attempted | Attention Deficit Hyperactivity Disorder | Post-traumatic Stress Disorder | Self Harm | Body Image Disorder | Eating Disorders | Adjustment Disorders | Anxiety Disorder | Depressive Episode | Behavioral Disorder | Psychological Disorder and other conditions

United Kingdom
Windtree Therapeutics
Momentum Research, Inc.

Not yet recruiting

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C (SEISMiC-C)

Cardiogenic Shock
Momentis Surgical

Recruiting

Anovo™ Surgical System - Registry Study

GYN Disorders

United States
Momentum Data
Pfizer; University of Surrey

Completed

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study

Rheumatoid Arthritis | Inflammatory Bowel Diseases | Crohn Disease | Deep Vein Thrombosis | Ulcerative Colitis | Venous Thromboembolism | Psoriatic Arthritis | Pulmonary Embolism | Venous Thromboses

United Kingdom
Momentum Data
Pfizer; University of Surrey

Completed

Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United Kingdom
Momentum Data
Pfizer; University of Oxford

Active, not recruiting

Healthcare Disparities in Alopecia Areata

Alopecia Areata

United Kingdom
University of Cape Town
Momentum Research, Inc.

Unknown

Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure (B-AHEF)

Acute Heart Failure | Left Ventricular Dysfunction

South Africa
Momenta Pharmaceuticals, Inc.

Terminated

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Immune Thrombocytopenic Purpura (ITP)

United States, Poland, Hungary, Netherlands, Italy, Spain, Belgium
Momenta Pharmaceuticals, Inc.

Terminated

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Belgium, Canada, Germany, Italy, Poland, Spain, United Kingdom
Momenta Pharmaceuticals, Inc.

Completed

Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects

Healthy

United States, United Kingdom
Momenta Pharmaceuticals, Inc.

Completed

An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Healthy Volunteers

Netherlands
Momenta Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Belgium, Canada, Germany, Italy, Poland, Spain, United Kingdom
Momenta Pharmaceuticals, Inc.

Completed

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) (EMINENCE)

Coronary Artery Disease (CAD)

United States, Canada
Momenta Pharmaceuticals, Inc.

Completed

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Psoriasis | Chronic Plaque Psoriasis

United States, Poland, Canada, Czechia, Estonia, Germany, Slovakia, Bulgaria, Latvia
Momenta Pharmaceuticals, Inc.

Terminated

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Metastatic Pancreatic Cancer

United States, Canada
Momenta Pharmaceuticals, Inc.

Completed

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Rheumatoid Arthritis

United States
Momentum Data
Pfizer; University of Oxford; University of Surrey

Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Multiple Sclerosis | Pneumonia | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Anxiety Disorders | Psoriasis | Asthma | Type 1 Diabetes | Graves Disease | Celiac Disease | Allergic Rhinitis | Urinary Tract Infections | Crohn Disease | Influenza | Ulcerative Colitis | Herpes Zoster | Herpes Simplex | Atopic Dermatitis | V... and other conditions

United Kingdom
Momentum Research, Inc.
Abbott; Saint-Louis-Lariboisière University Hospitals

Completed

NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure (NATRIUM-HF)

Heart Failure

Armenia, Bosnia and Herzegovina, Russian Federation
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Momenta Pharmaceuticals, Inc.
Mylan Inc.

Completed

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Healthy Volunteers

United Kingdom
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Momentum Data
Pfizer; Royal College of General Practitioners Research and Surveillance Centre

Unknown

Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema

United Kingdom
Momentum Wheels for Humanity
University of Pittsburgh; Universidad de El Salvador; Google LLC.

Completed

Effects of the WHO 8-step Wheelchair Service Delivery Process on Wheelchair Users in El Salvador: a Cohort Study (WUV)

Wheelchair Users

El Salvador
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) (DME)

Diabetic Macular Edema

Japan, United States, Czechia, Germany, Hungary, India, Latvia, Poland, Russian Federation
Heart Initiative
Roche Diagnostics; Momentum Research, Inc.; Hôpitaux Universitaires Saint-Louis-Lariboisière and other collaborators

Recruiting

Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies (STRONG-HF)

Heart Failure

Argentina, Austria, Colombia, France, Hungary, Israel, Mozambique, Nigeria, Russian Federation, Slovakia, South Africa, Tunisia
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Extension Study of MYL-1701P-3001 for Safety and Efficacy

Diabetic Macular Edema

India
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion

Clinical Trials Sponsored by Momentum Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations